| 3 | 💬 0 |
A multicenter randomized, double-blinded placebo-controlled phase 2 trial to evaluate safety and efficacy of ilofotase alfa in patients at risk for kidney injury following open heart surgery.
(link.springer.com)
|
Intensive Care Medicine 2026-09-21 | #nephroprotection #cardiac surgery #aki #immunomodulation |